Procept Gross Profit from 2010 to 2025

PRCT Stock

USD 58.10 0.00 0.00%

Procept Biorobotics Gross Profit yearly trend continues to be comparatively stable with very little volatility. Gross Profit is likely to outpace its year average in 2025. Gross Profit is the profit Procept Biorobotics Corp makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services. View All Fundamentals

Gross Profit

First Reported

2020-03-31

Previous Quarter

36.9 M

Current Value

43.7 M

Quarterly Volatility

12.9 M

Covid

Check Procept Biorobotics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Procept Biorobotics' main balance sheet or income statement drivers, such as Net Interest Income of 7 M, Interest Income of 11.4 M or Depreciation And Amortization of 4 M, as well as many indicators such as Price To Sales Ratio of 17.76, Dividend Yield of 0.0 or PTB Ratio of 10.96. Procept financial statements analysis is a perfect complement when working with Procept Biorobotics Valuation or Volatility modules.

Check out the analysis of Procept Biorobotics Correlation against competitors.

Latest Procept Biorobotics' Gross Profit Growth Pattern

Below is the plot of the Gross Profit of Procept Biorobotics Corp over the last few years. Gross profit is a required income statement account that reflects total revenue of Procept Biorobotics Corp minus its cost of goods sold. It is profit before Procept Biorobotics operating expenses, interest payments and taxes. Gross profit is also known as gross margin. It is the profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services. Procept Biorobotics' Gross Profit historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Procept Biorobotics' overall financial position and show how it may be relating to other accounts over time.

View

Last Reported 137.1 M

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Gross Profit

Timeline

Procept Gross Profit Regression Statistics

	Arithmetic Mean	24,059,184
	Coefficient Of Variation	206.35
	Mean Deviation	36,618,777
	Median	(1,885,000)
	Standard Deviation	49,645,026
	Sample Variance	2464.6T
	Range	145.8M
	R-Value	0.74
	Mean Square Error	1179.4T
	R-Squared	0.55
	Significance	0.001
	Slope	7,757,030
	Total Sum of Squares	36969.4T

Procept Gross Profit History

	2025	144 M
	2024	137.1 M
	2023	71 M
	2022	37.1 M
	2021	15.9 M
	2020	-1.3 M

Other Fundumenentals of Procept Biorobotics Corp

Gross Profit Margin

Procept Biorobotics Gross Profit component correlations

	Total Assets	Total Stockholder Equity	Net Tangible Assets	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Long Term Debt	Net Receivables	Total Liab	Net Invested Capital	Total Current Assets	Net Working Capital	Short Term Debt	Intangible Assets	Property Plant Equipment	Short Long Term Debt	Capital Surpluse	Deferred Long Term Liab	Common Stock
Total Assets		0.95	0.94	0.85	-0.95	-0.94	0.86	0.92	0.82	-0.74	0.96	1.0	1.0	-0.2	-0.98	0.86	-0.53	-0.53	-0.53	0.69
Total Stockholder Equity	0.95		0.98	0.9	-0.98	-0.95	0.81	0.88	0.86	-0.84	1.0	0.95	0.95	-0.29	-0.95	0.87	-0.68	-0.68	-0.68	0.68
Net Tangible Assets	0.94	0.98		0.79	-0.97	-0.88	0.79	0.89	0.74	-0.9	0.98	0.94	0.95	-0.26	-0.91	0.8	-0.54	-0.54	-0.54	0.54
Current Deferred Revenue	0.85	0.9	0.79		-0.83	-0.97	0.8	0.74	1.0	-0.57	0.89	0.84	0.83	-0.35	-0.91	0.93	-0.86	-0.86	-0.86	0.85
Net Debt	-0.95	-0.98	-0.97	-0.83		0.9	-0.72	-0.91	-0.8	0.81	-0.98	-0.96	-0.97	0.14	0.92	-0.79	0.63	0.63	0.63	-0.65
Retained Earnings	-0.94	-0.95	-0.88	-0.97	0.9		-0.89	-0.87	-0.95	0.65	-0.95	-0.93	-0.92	0.27	0.98	-0.96	0.73	0.73	0.73	-0.77
Accounts Payable	0.86	0.81	0.79	0.8	-0.72	-0.89		0.78	0.76	-0.63	0.82	0.84	0.81	-0.35	-0.91	0.91	-0.4	-0.4	-0.4	0.5
Long Term Debt	0.92	0.88	0.89	0.74	-0.91	-0.87	0.78		0.69	-0.62	0.89	0.92	0.92	0.1	-0.92	0.82	-0.47	-0.47	-0.47	0.5
Net Receivables	0.82	0.86	0.74	1.0	-0.8	-0.95	0.76	0.69		-0.52	0.86	0.81	0.79	-0.34	-0.88	0.91	-0.87	-0.87	-0.87	0.87
Total Liab	-0.74	-0.84	-0.9	-0.57	0.81	0.65	-0.63	-0.62	-0.52		-0.83	-0.75	-0.76	0.49	0.68	-0.56	0.35	0.35	0.35	-0.35
Net Invested Capital	0.96	1.0	0.98	0.89	-0.98	-0.95	0.82	0.89	0.86	-0.83		0.96	0.96	-0.27	-0.95	0.88	-0.68	-0.68	-0.68	0.67
Total Current Assets	1.0	0.95	0.94	0.84	-0.96	-0.93	0.84	0.92	0.81	-0.75	0.96		1.0	-0.19	-0.97	0.84	-0.53	-0.53	-0.53	0.69
Net Working Capital	1.0	0.95	0.95	0.83	-0.97	-0.92	0.81	0.92	0.79	-0.76	0.96	1.0		-0.18	-0.96	0.82	-0.53	-0.53	-0.53	0.68
Short Term Debt	-0.2	-0.29	-0.26	-0.35	0.14	0.27	-0.35	0.1	-0.34	0.49	-0.27	-0.19	-0.18		0.22	-0.34	0.28	0.28	0.28	-0.39
Intangible Assets	-0.98	-0.95	-0.91	-0.91	0.92	0.98	-0.91	-0.92	-0.88	0.68	-0.95	-0.97	-0.96	0.22		-0.94	0.62	0.62	0.62	-0.71
Property Plant Equipment	0.86	0.87	0.8	0.93	-0.79	-0.96	0.91	0.82	0.91	-0.56	0.88	0.84	0.82	-0.34	-0.94		-0.71	-0.71	-0.71	0.7
Short Long Term Debt	-0.53	-0.68	-0.54	-0.86	0.63	0.73	-0.4	-0.47	-0.87	0.35	-0.68	-0.53	-0.53	0.28	0.62	-0.71		1.0	1.0	-0.8
Capital Surpluse	-0.53	-0.68	-0.54	-0.86	0.63	0.73	-0.4	-0.47	-0.87	0.35	-0.68	-0.53	-0.53	0.28	0.62	-0.71	1.0		1.0	-0.8
Deferred Long Term Liab	-0.53	-0.68	-0.54	-0.86	0.63	0.73	-0.4	-0.47	-0.87	0.35	-0.68	-0.53	-0.53	0.28	0.62	-0.71	1.0	1.0		-0.8
Common Stock	0.69	0.68	0.54	0.85	-0.65	-0.77	0.5	0.5	0.87	-0.35	0.67	0.69	0.68	-0.39	-0.71	0.7	-0.8	-0.8	-0.8

Click cells to compare fundamentals

About Procept Biorobotics Financial Statements

Procept Biorobotics shareholders use historical fundamental indicators, such as Gross Profit, to determine how well the company is positioned to perform in the future. Although Procept Biorobotics investors may analyze each financial statement separately, they are all interrelated. The changes in Procept Biorobotics' assets and liabilities, for example, are also reflected in the revenues and expenses on on Procept Biorobotics' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.

	Last Reported	Projected for Next Year
Gross Profit	137.1 M	144 M
Gross Profit Margin	0.61	0.64

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Procept Stock Analysis

When running Procept Biorobotics' price analysis, check to measure Procept Biorobotics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Procept Biorobotics is operating at the current time. Most of Procept Biorobotics' value examination focuses on studying past and present price action to predict the probability of Procept Biorobotics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Procept Biorobotics' price. Additionally, you may evaluate how the addition of Procept Biorobotics to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC